Aptorum Group Ltd (APM) is a Cayman Islands holding company that operates in the pharmaceutical industry. Its subsidiaries and variable interest entities (VIEs) conduct the company's main business activities, which include the development of innovative therapies and diagnostic technologies. Aptorum's operations are spread across several countries, with a significant presence in Hong Kong. The company generates revenue through its therapeutics and non-therapeutics segments. The therapeutics segment focuses on developing innovative therapies for...
No data available.
No data available.
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | SMMT | Summit Therapeutics Inc. | 1,204.25 Bn | -1,306.67 | 0.00 | 0.01 Bn |
| 2 | ONC | BeOne Medicines Ltd. | 486.51 Bn | 7,097.20 | 97.84 | 1.90 Bn |
| 3 | VRTX | Vertex Pharmaceuticals Inc / Ma | 122.05 Bn | 30.87 | 10.17 | 1.85 Bn |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 83.00 Bn | 18.42 | 5.79 | 2.71 Bn |
| 5 | ARGX | Argenx Se | 50.78 Bn | 33.71 | 26,480.10 | - |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.66 Bn | 139.17 | 11.76 | 2.97 Bn |
| 7 | BNTC | Benitec Biopharma Inc. | 43.61 Bn | -941.82 | 0.00 | 0.00 Bn |
| 8 | INSM | INSMED Inc | 28.88 Bn | -24.40 | 64.61 | 0.74 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 0.40 | 11.06 | |
| EV to Cash from Ops. EV/CFO | -10.04 | 26.32 | |
| EV to Debt EV to Debt | 2.14 | 762.61 | |
| EV to EBIT EV/EBIT | -3.75 | -13.49 | |
| EV to EBITDA EV/EBITDA | -2.00 | 8.61 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | -10.04 | 25.66 | |
| EV to Market Cap EV to Market Cap | 1.52 | 203.37 | |
| EV to Revenue EV/Rev | 0.00 | 156.31 | |
| Price to Book Value [P/B] P/B | 0.21 | 20.59 | |
| Price to Earnings [P/E] P/E | -2.32 | -0.88 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | -12.64 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 0.00 | 0.17 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.01 | |
| FCF Dividend Payout Ratio % FCF Dividend Payout Ratio % | 0.00 | -0.14 | |
| Interest Coverage Int. cover (Qtr) | -15.53 | 956.66 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex Growth (1y) % | 0.00 | 7.87 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 252.06 | 753.48 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | 0.01 | |
| EBIAT Growth (1y) % EBIAT Growth (1y) % | -1,790.74 | -57.63 | |
| EBITDA Growth (1y) % EBITDA Growth (1y) % | 0.00 | 8.83 | |
| EBIT Growth (1y) % EBIT Growth (1y) % | -1,790.74 | -67.21 | |
| EBT Growth (1y) % EBT Growth (1y) % | -11,170.09 | -23.74 | |
| EPS Growth (1y) % EPS Growth (1y) % | -209.68 | -7.02 | |
| FCF Growth (1y) % FCF Growth (1y) % | 74.21 | -40.48 | |
| Gross Profit Growth (1y) % Gross Profit Growth (1y) % | 0.00 | 264.51 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Utilization Ratio | 0.00 | 0.14 | |
| Cash Payout Ratio Cash Payout Ratio | 0.00 | 0.00 | |
| Cash Ratio Cash Ratio (Qtr) | 2.74 | 3.92 | |
| Current Ratio Curr Ratio (Qtr) | 2.98 | 7.33 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.15 | 0.48 | |
| Interest Cover Ratio Int Coverage (Qtr) | -15.53 | 956.66 | |
| Times Interest Earned Times Interest Earned (Qtr) | -15.53 | 956.66 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % | 0.00 | -17,888.70 | |
| EBIT Margin % EBIT Margin % | 0.00 | -18,246.34 | |
| EBT Margin % EBT Margin % | 0.00 | -19,108.08 | |
| Gross Margin % Gross Margin % | 0.00 | -10.30 | |
| Net Profit Margin % Net Profit Margin % | 0.00 | -19,056.96 |